Regencell Bioscience Holding Stock price
Compare with Peer Group
Is Regencell Bioscience Holding a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Don't miss a Thing! We will send you all news about Regencell Bioscience Holding directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Regencell Bioscience Holding Stock News
Company Profile
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
| Head office | Cayman Islands |
| Employees | 10 |
| Website | www.regencellbioscience.com |


